Ribavirin Mylan 200 mg hard capsules

ATC Code
Medikamio Hero Image

About this drug

Admission country
Manufacturer Generics [UK] Ltd.
Narcotic drug No
Psychotropic No


All to know


Generics [UK] Ltd.

What is it?

Ribavirin Mylan is a medicine that contains the active substance ribavirin. It is available as white capsules (200 mg).

Ribavirin Mylan is a ?generic medicine?. This means that Ribavirin Mylan is similar to a ?reference medicine? already authorised in the European Union (EU) called Rebetol. For more information on generic medicines, see the question-and-answer document here.

What is it used for?

Ribavirin Mylan is used to treat long-term hepatitis C (a disease of the liver due to infection with the hepatitis C virus) in patients aged three years and older. Ribavirin Mylan must never be used on its own but only together with interferon alfa-2b (another medicine used in hepatitis).

Ribavirin Mylan is used in patients who have not been treated before, as long as the liver is still working and hepatitis C virus can be found in the blood. Ribavirin Mylan can also be used in adults whose disease has come back after previous treatment or whose previous treatment failed.

The medicine can only be obtained with a prescription.

1 Previously known as Ribavirin Three Rivers


How is it used?

Treatment with Ribavirin Mylan should be started and monitored by a doctor who has experience in the management of long-term hepatitis C. The dose of Ribavirin Mylan is based on the patient?s body weight, and ranges from three to seven capsules a day. It can only be used in patients who weigh more than 47 kg. Ribavirin Mylan is taken with food each day in two divided doses (morning and evening). The duration of treatment depends on the patient?s condition and response to treatment, and ranges from six months to a year. The dose may need to be adjusted for patients who experience side effects. For more information, see the Package Leaflet.

How does it work?

The active substance in Ribavirin Mylan, ribavirin, is an antiviral belonging to the class ?nucleoside analogues?. Ribavirin Mylan is thought to interfere with the production or action of viral DNA and RNA, which are needed for viruses to survive and multiply. Ribavirin Mylan on its own has no effect on eliminating the hepatitis C virus from the body.

How has it been studied?

Because Ribavirin Mylan is a generic medicine, studies in patients have been limited to tests to determine that it is bioequivalent to the reference medicine, Rebetol. Two medicines are bioequivalent when they produce the same levels of the active substance in the body.

What benefits has it shown during the studies?

Because Ribavirin Mylan is a generic medicine and is bioequivalent to the reference medicine, its benefit and risk are taken as being the same as the reference medicine.

What is the risk associated?

Because Ribavirin Mylan is a generic medicine and is bioequivalent to the reference medicine, its benefit and risk are taken as being the same as the reference medicine.

Why has it been approved?

The CHMP concluded that, in accordance with EU requirements, Ribavirin Mylan has been shown to have comparable quality and to be bioequivalent to Rebetol. Therefore, the CHMP?s view was that, as for Rebetol, the benefit outweighs the identified risk. The Committee recommended that Ribavirin Mylan be given marketing authorisation.



Your personal medicine assistent


Search our database for drugs, sorted from A-Z with their effects and ingredients.


All substances with their common uses, chemical components and medical products which contain them.

The contents shown do not replace the original package insert of the medicinal product, especially with regard to dosage and effect of the individual products. We cannot assume any liability for the correctness of the data, as the data was partly converted automatically. A doctor should always be consulted for diagnoses and other health questions. Further information on this topic can be found here.

This website is certified by Health On the Net Foundation. Click to verify.